Impact of Acute Hospitalisation and Resistance Training on Muscle Architecture and Physical Performance in Older Adults

NCT05798169 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 274

Last updated 2025-03-27

No results posted yet for this study

Summary

Sarcopenia characterised by loss of muscle mass, muscle strength and physical performance burdens many older adults since the condition is related to functional decline. Periods of inactivity such as during hospitalisation leads to further functional decline. It has been reported that the loss of muscle mass associated with sarcopenia not only entails a decrease in muscle mass but also changes in muscle architecture. Knowledge on changes in muscle architecture is essential since it is one of the most important determinants on muscle strength and thus physical performance. The main objective of this study is to investigate changes in muscle architecture and physical performance during acute hospitalisation and after discharge in older adults and subsequently the effectiveness of resistance training of the lower limb during acute hospitalisation. If successful, our study could have a great impact on the individual, as well as societal level, due to a better understanding of the factors related to sarcopenia and the prevention of functional decline as a result of hospitalisation.

Conditions

  • Sarcopenia
  • Functional Decline
  • Muscle Architecture
  • Gait Speed
  • Ultrasound
  • Physical Performance
  • Resistance Training
  • Hospitalisation
  • Acutely Ill
  • Older Adults

Interventions

OTHER

Resistance training

Moderate resistance training by a innovative training robot 2 times a day during hospitalisation

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER
  • Nottingham University Hospitals NHS Trust

    collaborator OTHER
  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Kristian B Buhl, MD · Department of Geriatric, Odense University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-05
Primary Completion
2024-12-20
Completion
2024-12-20

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05798169 on ClinicalTrials.gov